Literature DB >> 10492141

Morphologic progression of pedunculated submucosal invasive colon cancer.

K Saito1, M Mori.   

Abstract

To clarify the morphologic progression of pedunculated submucosal invasive colon cancers, we assessed the morphologic changes in 50 such cancers according to the volume of cancer in the submucosal layer. The shape of the head of the polyp was defined at the widest slice as round, concave, or semicircular with a horizontal head (SHH). As the cancer invaded the submucosa, the peduncle of the submucosal invasive cancer thickened and the structure of the head progressively collapsed, causing its shape to change from round to concave to SHH. The proliferating cell nuclear antigen (PCNA) expression (labeling index, LI), determined at the deepest point of submucosal invasion, showed a significant correlation with the morphologic progression among round, concave, and SHH cancers as 36.4 +/- 12.1%, 42.3 +/- 11.8%, and 62.1 +/- 12.5%, respectively (P < 0.05). Results indicate that the PCNA-LI may be a useful marker for the morphologic progression of pedunculated submucosal invasive colon cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492141     DOI: 10.1023/a:1026671228736

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma.

Authors:  R Kim; M R Clarke; M F Melhem; M A Young; M M Vanbibber; A V Safatle-Ribeiro; U Ribeiro; J C Reynolds
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

3.  Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells.

Authors:  M Zuber; E M Tan; M Ryoji
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

4.  The clinical significance of the histologic subclassification of colorectal carcinoma.

Authors:  C R Teixeira; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto
Journal:  Oncology       Date:  1993 Nov-Dec       Impact factor: 2.935

5.  Cell proliferation in colorectal adenomas containing invasive carcinoma.

Authors:  M Risio; F P Rossini
Journal:  Anticancer Res       Date:  1993 Jan-Feb       Impact factor: 2.480

6.  Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.

Authors:  N A Shepherd; P I Richman; J England
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

7.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  Ki-67 antibody labeling index in colorectal carcinoma.

Authors:  H Suzuki; K Matsumoto; M Terabe
Journal:  J Clin Gastroenterol       Date:  1992-12       Impact factor: 3.062

9.  Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas.

Authors:  C R Teixeira; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

10.  Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.

Authors:  A Yamaguchi; S Takegawa; T Ishida; G Nishimura; M Kato; M Kanno; T Kosaka; Y Yonemura; I Miyazaki
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  1 in total

1.  Morphologic progression of polypoid colon cancer invading muscularis propria.

Authors:  K Saito; K Arai; M Mori
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.